[1]
A. O. S. Adlan, “A Meta-Analysis of PCSK9 Inhibitors Versus Statins for LDL Cholesterol Reduction and Cardiovascular Outcomes”, ccm, vol. 9, no. 6, pp. 491–498, Dec. 2025.